1-3 of 3
AnnaRita Tagliaferri, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Type of Factor VIII Product as Inhibitor Risk Factor in Patients with Severe Hemophilia A and Null Mutations.

Maria Elisa Mancuso, MD, PhD, Pier Mannuccio Mannucci, MD, Angiola Rocino, MD, Isabella Garagiola, PhD, AnnaRita Tagliaferri, MD, Maurizio Margaglione, MD, Elena Santagostino, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3500.
https://doi.org/10.1182/blood.V114.22.3500.3500
Published: 2009
Journal Articles

Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions.

Guglielmo Mariani, MD, Angelika Batorova, MD, Alberto Dolce, PhD, Sergio Siragusa, MD, Mario Lapecorella, MD, Jens Bierre Knudsen, MD, Giovanni Di Minno, MD, Elvira Grandone, MD, Giuseppe Tagariello, MD, AnnaRita Tagliaferri, MD, Guenter K.H. K.H. Auerswald, Sr., MD, Jørgen Ingerslev, MD
Journal: Blood
Blood (2009) 114 (22): 1290.
https://doi.org/10.1182/blood.V114.22.1290.1290
Published: 2009
Journal Articles

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

Elena Santagostino, MD, PhD, Angiola Rocino, MD, Maria E. Mancuso, MD, Maria G. Mazzucconi, MD, Giacomo Mancuso, MD, Maria Messina, MD, Annarita Tagliaferri, MD, Matteo Luciani, MD, Elio Boeri, MD, Pier M. Mannucci, MD
Journal: Blood
Blood (2004) 104 (11): 37.
https://doi.org/10.1182/blood.V104.11.37.37
Published: 2004